Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05131399

Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment

Led by Thuasne · Updated on 2024-09-23

20

Participants Needed

8

Research Sites

139 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to assess the superiority in achieving personal goals (set by the patient and the medical team) according to the GAS scale (Goal Attainment Scaling) while wearing the carbon medical device Ankle Foot Orthosis (AFO) compared to a standard plastic ankle foot orthosis.

CONDITIONS

Official Title

Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with a foot levator muscles impairment (single or bilateral drop foot) and/or instability of the back of the foot, with a triceps deficit
  • Patient unable to stand on tip-toe on one foot
  • Patient who has signed a free and informed consent
  • Patient affiliated or entitled to a social security scheme
Not Eligible

You will not qualify if you...

  • Patient with fixed varus-equine foot
  • Patient with unstable skin condition affecting footwear
  • Patient with foot levator muscle impairment plus quadriceps and hamstrings deficiency (knee involvement)
  • Patient with uncontrolled spasticity
  • Patient with planned foot surgery during the study
  • Patient with contraindications to carbon medical device as per instructions for use
  • Patient with contraindications to standard plastic ankle foot orthosis as per instructions for use
  • Patient with orthopedic comorbidities affecting the musculoskeletal system
  • Pregnant woman
  • Patient with major cognitive impairment incompatible with trial participation
  • Patient participating in another clinical investigation affecting evaluation criteria
  • Patient unable to be followed for 12 weeks
  • Vulnerable patient per article L1121-6 of the public health code or unable to consent freely

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Ch Les Capucins

Angers, France

Actively Recruiting

2

Chu Dijon

Dijon, France

Actively Recruiting

3

CH LAVAL

Laval, France

Actively Recruiting

4

CHU Lille

Lille, France

Actively Recruiting

5

centre Louis PIERQUIN

Nancy, France

Not Yet Recruiting

6

CHU Nantes

Nantes, France

Actively Recruiting

7

Hôpital Rothschild

Paris, France

Actively Recruiting

8

CHU Strasbourg

Strasbourg, France

Not Yet Recruiting

Loading map...

Research Team

P

Philippe THOUMIE, MD PhD

CONTACT

A

Astrid PICOLET

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here